Yanfang Ding
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
Papers in
-
- Circular RNAs in diseases 5
- RNA Research and Splicing 3
-
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 3
- Co-authors
- Changyuan Wang (9 shared papers)Shiying Cui (8 shared papers)Lei Li (6 shared papers)Jing Zhao (3 shared papers)Youwei Xu (8 shared papers)Gordon Guo (6 shared papers)Jinyao Zhao (8 shared papers)Chun Peng (3 shared papers)
- Journals
- Pharmaceutical Development and Technology (4 papers)Frontiers in Bioengineering and Biotechnology (1 paper)Cancer Cell International (1 paper)Journal of Tissue Engineering and Regenerative Medicine (1 paper)Molecular and Cellular Biochemistry (1 paper)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Yanfang Ding
23 papers receiving 717 citations
Peers
Comparison fields: 5 of 82
- Cancer Research 245
- Pharmaceutical Science 81
- Molecular Medicine 45
- Biomaterials 112
- Pharmacology 59
Countries citing papers authored by Yanfang Ding
This map shows the geographic impact of Yanfang Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanfang Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanfang Ding more than expected).
Fields of papers citing papers by Yanfang Ding
This network shows the impact of papers produced by Yanfang Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanfang Ding. The network helps show where Yanfang Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Yanfang Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 115 | |
| 2 | 2016 | 91 | |
| 3 | 2016 | 63 | |
| 4 | 2017 | 59 | |
| 5 | 2018 | 55 | |
| 6 | 2014 | 54 | |
| 7 | 2013 | 48 | |
| 8 | 2019 | 32 | |
| 9 | 2020 | 28 | |
| 10 | 2016 | 27 | |
| 11 | 2015 | 22 | |
| 12 | 2018 | 22 | |
| 13 | 2022 | 20 | |
| 14 | 2019 | 19 | |
| 15 | 2013 | 16 | |
| 16 | 2020 | 16 | |
| 17 | 2021 | 10 | |
| 18 | 2007 | 9 | |
| 19 | 2022 | 8 | |
| 20 | 2020 | 6 |
About Yanfang Ding
Yanfang Ding is a scholar working on Molecular Biology, Cancer Research, Biomaterials, Biomedical Engineering and Pharmacology, having authored 24 papers that have together received 727 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (8 papers), Nanoparticle-Based Drug Delivery (5 papers), Circular RNAs in diseases (5 papers), Ovarian cancer diagnosis and treatment (3 papers), RNA Research and Splicing (3 papers), Cancer-related molecular mechanisms research (3 papers), Nanoplatforms for cancer theranostics (3 papers) and Porphyrin and Phthalocyanine Chemistry (2 papers). The work is most often cited by research in Cancer Research (245 citations), Pharmaceutical Science (81 citations), Molecular Medicine (45 citations), Biomaterials (112 citations) and Pharmacology (59 citations). Yanfang Ding has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Changyuan Wang, Shiying Cui, Lei Li, Jing Zhao, Youwei Xu, Gordon Guo, Jinyao Zhao, Chun Peng, Yutong Wang and Jiyong Jiang. Their work appears in journals such as Pharmaceutical Development and Technology, Frontiers in Bioengineering and Biotechnology, Cancer Cell International, Journal of Tissue Engineering and Regenerative Medicine and Molecular and Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.